Risk Management Principles for Devices and Pharmaceuticals, Third Edition page 98

Section II: Benefit-Risk Management Principles and Practices
Chapter 6: The Impact of Preclinical Planning and Study Outcome on the Risk Management of Biologicals
98

Previous Page Next Page

Purchased from RAPS Library (library.raps.org) for the exclusive use of unknown.
© 2026 RAPS Library. Please report unauthorized use to raps@raps.org

Risk Management Principles for Devices and Pharmaceuticals, Third Edition Page 98 (109 of 392)

Risk Management Principles for Devices and Pharmaceuticals, Third Edition resources

Help